In this article, we are going to look at the 5 Best Blue Chip Stocks Under $100 to Buy Now. For a longer list and more details on how we picked these stocks, you can go to 10 Best Blue Chip Stocks Under $100 to Buy Now.
5. Delta Air Lines, Inc. (NYSE:DAL)
Market Cap: $52.1 billion
Stock Price: $78.78
Number of Hedge Fund Holders: 68
Delta Air Lines, Inc. (NYSE:DAL) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On May 29, Deutsche Bank lifted its price objective on the company’s stock to $90 from $80 and maintained a “Buy” rating on the shares. As per the firm, the airlines capable of making positive ROIC in excess of the weighted average cost of capital tend to be well-placed to pay their debt and return capital to their shareholders.
Furthermore, the analyst added that such airlines remain in a much better shape to tackle the industry downturn, whether it’s economical or due to geopolitical concerns. The firm added that only some of the US airlines can demonstrate the durability and resiliency of earnings and FCF in the environment that has been impacted by geopolitical concerns. The firm adjusted its price objectives in the broader airlines group, which was part of the value creation primer.
Delta Air Lines, Inc. (NYSE:DAL) is engaged in offering scheduled air transportation for passengers and cargo.
4. Abbott Laboratories (NYSE:ABT)
Market Cap: $157.2 Billion
Stock Price: $86.99
Number of Hedge Fund Holders: 73
Abbott Laboratories (NYSE:ABT) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On May 27, analyst David Roman from Goldman Sachs maintained a “Buy” rating on the company’s stock and reduced the price objective to $113.00 from $121.00. The analyst’s rating is supported by several factors that highlight improvements in fundamentals and an attractive risk-reward profile. Notably, the analyst pointed to the clear bridge from softer early-2026 trends to healthier growth later, thanks to the accelerated sales in Nutrition, Devices, and Diagnostics, and specific product ramps like Libre and new Electrophysiology launches.
Furthermore, the analyst hinted at a visible path focused on margin expansion and earnings leverage in 2026 and beyond, amid potential improvement in sentiment as execution becomes evident. While the analyst acknowledged the challenges that Abbott Laboratories (NYSE:ABT) might face in the near-term, the current valuation remains compelling relative to the company’s growth profile. Also, optional catalysts, such as favorable reimbursement decisions and share repurchases, can result in further upside, added Roman.
Abbott Laboratories (NYSE:ABT) is engaged in discovering, developing, manufacturing, and selling health care products.
3. The Williams Companies, Inc. (NYSE:WMB)
Market Cap: $88 Billion
Stock Price: $71.66
Number of Hedge Fund Holders: 84
The Williams Companies, Inc. (NYSE:WMB) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On May 26, CIBC lifted its price objective on the company’s stock to $85 from $83 and maintained an “Outperform” rating on the shares. It updated the models in the broader energy infrastructure space after the earnings releases for Q1. As per the analyst, the mid-streamers highlighted the guidance upside if the market conditions continue to hold.
Notably, The Williams Companies, Inc. (NYSE:WMB) posted strong Q1 2026 results, amidst the success of its natural gas-focused strategy as well as the performance of its premier assets. The company’s Q1 2026 GAAP net income went up by 25% YoY to $864 million, while adjusted EBITDA rose by 13% YoY to $2.254 billion, thanks to Transco’s expansion projects, new Gulf volumes, increased storage revenues, and elevated gathering volumes in the West.
For FY 2026, The Williams Companies, Inc. (NYSE:WMB) expects 2026 adjusted EBITDA of between $8.05 billion – $8.35 billion.
The Williams Companies, Inc. (NYSE:WMB) operates as an energy infrastructure company.
2. CVS Health Corporation (NYSE:CVS)
Market Cap: ~$122.3 billion
Stock Price: $91.37
Number of Hedge Fund Holders: 84
CVS Health Corporation (NYSE:CVS) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On June 1, Truist lifted its price objective on the company’s stock to $108 from $102 and maintained a “Buy” rating on the shares. This forms part of the research note on the broader managed healthcare companies. The analyst highlighted that the firm expects significant embedded earnings potential that is associated with the ongoing margin recovery throughout the government businesses.
Furthermore, there are expectations of continued robust trends in the commercial business. The firm added that the Q1 medical cost trends were favourable to the consensus expectations of the analysts.
Notably, in Q1 2026, CVS Health Corporation (NYSE:CVS)’s total revenues came in at $100.4 billion, reflecting a rise of 6.2% YoY, with GAAP diluted EPS coming at $2.30 and adjusted EPS at $2.57. The company raised its FY 2026 guidance, with GAAP diluted EPS now expected to be between $6.24 – $6.44 compared to the previous range of $5.94 – $6.14.
CVS Health Corporation (NYSE:CVS) offers health solutions.
1. Netflix, Inc. (NASDAQ:NFLX)
Market Cap: ~$346.0 billion
Stock Price: $81.52
Number of Hedge Fund Holders: 144
Netflix, Inc. (NASDAQ:NFLX) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On June 4, Bernstein reiterated an “Outperform” rating and a price objective of $110.00 on the company’s stock. There are numerous factors that are impacting sentiments. These include the continued adoption of short-form and vertical content, stepped-up content spending, margin pressure, etc. The firm noted that when Netflix, Inc. (NASDAQ:NFLX) was performing well, the narrative was backed by robust growth in subscribers, pricing power, and growth in operating leverage resulting in the margin expansion and EPS growth.
Such core drivers are intact, added the firm, while highlighting that the law of large numbers is impacting the outlook. The other long-term uncertainties are AI, engagement, and a shift in consumer expectations. As per the analyst, Netflix, Inc. (NASDAQ:NFLX) happens to be a low‑cost streaming utility, which has a big room to grow outside the English‑speaking markets. The company’s business model is solid despite concerns.
Netflix, Inc. (NASDAQ:NFLX) is engaged in offering entertainment services.
While we acknowledge the potential of NFLX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NFLX and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
